Taken together, the results from the two treatment studies demonstrated that DTH arthritis can be suppressed by systemic administration of TNFα-blocking biologics whether administration was prophylactic, at the time of DTH-arthritis induction, or therapeutic from day 1 after DTH-arthritis induction, when paw swelling had reached peak level. Here, TNF is linked to arthritic joint disease.